SCHEMBL7051358

SCHEMBL7051358

CCCCOC(=O)NCC1CCNCC1

nearest known ligand 0.49

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 2/20 0.49
GNAO1 P09471 2/20 0.49
GNAI1 P63096 2/20 0.49
ALOX15 P16050 2/20 0.47
ACHE P22303 11/20 0.46
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3701010 0.91 ACHE (0.44) GNAI3GNAO1GNAI1ACHE
SCHEMBL16145641 0.89 ACHE (0.53) ACHE
SCHEMBL14469954 0.86 ACHE (0.47) ACHE
SCHEMBL13387497 0.84 ACHE (0.49) ACHE
SCHEMBL3417041 0.84 ALOX15 (0.51) GNAI3GNAO1GNAI1ALOX15TSHR
SCHEMBL8258529 0.83 ACHE (0.47) ACHE
SCHEMBL27694206 0.83 IGLV6-57 (0.50) ACHE
Hydrochloric Acid SCHEMBL29890675 0.83 ALOX15 (0.50) GNAI3GNAO1GNAI1ALOX15TSHR
SCHEMBL10794458 0.83 ACHE (0.59) ACHE
SCHEMBL29991951 0.82 ACHE (0.55) GNAI3GNAO1GNAI1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025046523-A1 NOVEL PYRIDO PYRIDAZINONE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 삼진제약주식회사 2025-03-06 WO disclosed
EP-4097096-A2 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 EP disclosed
EP-1301464-A1 BIPHENYLCARBOXYLIC ACID AMIDES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2003-04-16 EP disclosed
WO-2002004403-A1 BIPHENYLCARBOXYLIC ACID AMIDES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-01-17 WO disclosed